Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,859 | 9,078 | 6,125 | 210 | 0 |
| Receivables | 304 | 150 | N/A | N/A | 0 |
| Other current assets | 40 | 42 | 42 | 45 | 0 |
| TOTAL | $8,330 | $9,435 | $6,325 | $336 | $0 |
| Non-Current Assets | |||||
| PPE Net | 98 | 115 | 101 | 78 | N/A |
| TOTAL | $98 | $115 | $101 | $78 | $N/A |
| Total Assets | $8,428 | $9,549 | $6,426 | $414 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 131 | 197 | 209 | 309 | 0 |
| Accrued Expenses | 119 | 33 | 333 | 156 | 0 |
| TOTAL | $250 | $230 | $542 | $464 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,526 | 12,022 | 8,383 | 0 | 0 |
| TOTAL | $8,526 | $12,022 | $8,383 | $N/A | $N/A |
| Total Liabilities | $8,775 | $12,252 | $8,924 | $464 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 72 | 72 | 66 | 50 | 0 |
| Retained earnings | -11,861 | -14,190 | -12,688 | -5,054 | 0 |
| Other shareholders' equity | 42 | 42 | 42 | 17 | 0 |
| TOTAL | $-347 | $-2,703 | $-2,499 | $-50 | $0 |
| Total Liabilities And Equity | $8,428 | $9,549 | $6,426 | $414 | $0 |